Pfizer (PFE) FCF Payout Ratio (2009 - 2026)

Pfizer has disclosed FCF Payout Ratio across 18 years of filings, most recently posting 1.12 for Q1 2026.

• In Q1 2026, FCF Payout Ratio fell 18.46% year-over-year to 1.12; the TTM figure through Mar 2026 stood at 1.03 (down 75.63% YoY), while the FY2025 annual figure was 1.08, up 11.33% from the prior year.
• FCF Payout Ratio grew to 1.12 in Q1 2026, from 0.54 in the prior quarter.
• Over the last five years, FCF Payout Ratio for PFE reached as high as 31.55 in Q2 2023 and fell as low as 2.04 in Q2 2025.
• The 5-year median for FCF Payout Ratio is 0.55 (2023), against an average of 2.77.
• The widest YoY moves for FCF Payout Ratio: up 8173.45% in 2023, down 460.69% in 2023.
• A 5-year view of FCF Payout Ratio shows it stood at 0.37 in 2022, then soared by 51.07% to 0.55 in 2023, then jumped by 220.69% to 1.77 in 2024, then sank by 69.31% to 0.54 in 2025, then surged by 106.65% to 1.12 in 2026.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 1.12, 0.54, and 0.61 for Q1 2026, Q4 2025, and Q3 2025 respectively.